Reaction Risk to Direct Penicillin Challenges
Authors:
Top Cited Papers
- 1 November 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 184 (11) , 1374-1383
Abstract
Importance: While direct penicillin challenges might support the expansion of penicillin allergy delabeling efforts, the perceived risk of reactions remains a key barrier.Objective: To evaluate the frequency of reactions to direct penicillin challenges in individuals with penicillin allergy labels and to identify factors associated with such reactions.Data Sources: Three electronic databases were searched (MEDLINE, Web of Science, and Scopus) from inception to July 19, 2023, for primary studies assessing patients undergoing direct penicillin challenges. Articles were included regardless of publication year, language, status, or definition of allergy risk.Study Selection: Two reviewers independently selected original studies reporting the frequency of immunologically mediated reactions following a direct penicillin challenge in patients reporting a penicillin allergy.Data Extraction and Synthesis: Two reviewers independently extracted data and independently assessed the quality of each primary study using a risk-of-bias tool for prevalence studies.Main Outcomes and Measures: The primary outcome was the frequency of reactions to direct penicillin challenges as calculated using random-effects bayesian meta-analysis of proportions. Secondary outcomes included risk factors for reactions and the frequency of severe reactions.Results: A total of 56 primary studies involving 9225 participants were included. Among participants, 438 experienced reactions to direct penicillin challenges without prior testing, corresponding to an overall meta-analytic frequency of 3.5% (95% credible interval [CrI], 2.5%-4.6%). Meta-regression analyses revealed that studies performed in North America had lower rates of reaction to direct challenges (odds ratio [OR], 0.36; 95% CrI, 0.20-0.61), while studies performed in children (OR, 3.37; 95% CrI, 1.98-5.98), in outpatients (OR, 2.19; 95% CrI, 1.08-4.75), and with a graded (OR, 3.24; 95% CrI, 1.50-7.06) or prolonged (OR, 5.45; 95% CrI, 2.38-13.28) challenge had higher rates of reaction. Only 5 severe reactions (3 anaphylaxis, 1 fever with rash, and 1 acute kidney injury) were reported, none of which were fatal.Conclusions and Relevance: This systematic review and meta-analysis found that reactions to direct penicillin challenges are infrequent, with rates comparable to indirect challenges after allergy testing. These findings suggest that direct challenges are safe for incorporation into penicillin allergy evaluation efforts across age groups and clinical settings.Keywords
This publication has 67 references indexed in Scilit:
- Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin AllergyJAMA Internal Medicine, 2023
- Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta‐analysisClinical and Translational Allergy, 2021
- Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care HospitalJAMA Network Open, 2021
- MOOSE Reporting Guidelines for Meta-analyses of Observational StudiesJAMA Surgery, 2021
- Association Between Penicillin Allergy Documentation and Antibiotic UseJAMA Internal Medicine, 2020
- β‐Lactam allergy testing and delabeling—Experiences and lessons from SingaporeImmunity, Inflammation and Disease, 2020
- A Closer Look at Penicillin Allergy History: Systematic Review and Meta-Analysis of Tolerance to Drug ChallengeThe American Journal of Medicine, 2020
- Recorded Penicillin Allergy and Risk of Mortality: a Population-Based Matched Cohort StudyJournal of General Internal Medicine, 2019
- Evaluation and Management of Penicillin AllergyJAMA, 2019
- Short protocol for the study of paediatric patients with suspected betalactam antibiotic hypersensitivity and low risk criteriaAllergologia et Immunopathologia, 2011